NEW ENTERPRISE ASSOCIATES 13, L.P. - RHYTHM PHARMACEUTICALS, INC. 13D

Company

RHYTHM PHARMACEUTICALS, INC.

Filed

October 13, 2017

Accession Number

0001072613-17-000514

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →